Market Capitalization (Millions $) |
56 |
Shares
Outstanding (Millions) |
24 |
Employees |
- |
Revenues (TTM) (Millions $) |
6 |
Net Income (TTM) (Millions $) |
-20 |
Cash Flow (TTM) (Millions $) |
5 |
Capital Exp. (TTM) (Millions $) |
0 |
Inspiremd Inc
Inspiremd Inc is a medical technology company that specializes in developing and commercializing neurovascular devices. Their flagship product is the CGuard'' Embolic Prevention System, which is used to prevent strokes caused by the blockage of blood vessels in the brain. This innovative system is designed to capture and remove potential emboli during various endovascular procedures. Inspiremd Inc aims to provide effective and minimally invasive solutions for improving patient outcomes in the field of neurovascular medicine.
Company Address: 4 Menorat Hamaor St. Tel Aviv 6744832
Company Phone Number: 776-6804 Stock Exchange / Ticker: NASDAQ NSPR
NSPR is expected to report next financial results on March 29, 2024. |
|
|